Insta
US FDA Clears Johnson & Johnson's Single-Dose COVID Vaccine; J&J To Produce A Billion Doses By End Of Year
Vaccination drive.
In a major development, the United States (US)' Food and Drug Administration (FDA) has cleared the world's first single-dosage COVID-19 vaccine developed by pharmaceutical major Johnson & Johnson (J&J), reports Economic Times.
Approving the vaccine for usage, FDA said that J&J's vaccine offers strong protection against serious illness, hospitalisation need and death. It noted that a single dosage was 85 per cent protective against the most severe COVID-19 illness as per the massive study conducted across three continents.
Overall, J&J plans to produce a billion doses of the vaccine for global supplies by the end of the year. It is also seeking authorisation for emergency use of its vaccine in Europe and from the World Health organisation (WHO).
It should be noted that Bahrain cleared the usage of J&J's vaccine before the US on Thursday (25 February) itself.
Introducing ElectionsHQ + 50 Ground Reports Project
The 2024 elections might seem easy to guess, but there are some important questions that shouldn't be missed.
Do freebies still sway voters? Do people prioritise infrastructure when voting? How will Punjab vote?
The answers to these questions provide great insights into where we, as a country, are headed in the years to come.
Swarajya is starting a project with an aim to do 50 solid ground stories and a smart commentary service on WhatsApp, a one-of-a-kind. We'd love your support during this election season.
Click below to contribute.
Latest
